Research On Financial Risk Identification And Control Of Cross-border M & A Of Private Enterprises

Under the strategic background of "The Belt and Road Initiative",more and more private enterprises in China choose cross-border mergers and acquisitions to enhance their comprehensive strength.Cross-border mergers and acquisitions can not only bring rich resources,advanced technology and management experience to enterprises,but also It is beneficial for companies to enhance their international influence.Cross-border mergers and acquisitions have many benefits,but because they are more complicated than domestic general mergers and acquisitions,there are also many risks throughout the merger process,the most important of which is financial risk.The valuation risk before the merger is still the financing risk,payment risk in the merger or acquisition,or the integration risk after the merger.The risk of each link may lead to the failure of the entire merger and acquisition plan.Therefore,when private companies are conducting cross-border mergers and acquisitions We must pay attention to various financial risks that may exist in the process of mergers and acquisitions,and take necessary measures to control financial risks,thereby improving the success rate of mergers and acquisitions.This article takes Lanfan Medical M & A Bosheng International as an example,and it is specifically divided into seven parts to discuss.The first part mainly introduces the background and significance of the research,the identification,evaluation,prevention and control of financial risks in cross-border M & A at home and abroad Research results,research content and methods,research ideas and possible innovations in the aspect;the second part is the core concepts and related theoretical foundations;the third part mainly introduces the case briefly,including the company profile of both parties of the merger and acquisition,this time The motivation and process of M & A;the fourth part first uses factor analysis to identify the main financial risks in the transaction,and then analyzes the possible financial risks in stages;the fifth part mainly uses the Zscore model and indicator analysis The law comprehensively analyzes the financial risk of this M & A transaction;the sixth part is a specific analysis of the control measures taken by Lanfan Medical against the above financial risks;the seventh part is the conclusion,which is mainly based on the analysis and research of this case Draw corresponding conclusions,and propose general recommendations for other private enterprises to control financial risks when carrying out cross-border mergers and acquisitionsAnd research prospects of individuals.